Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-069143
Filing Date
2012-12-21
Accepted
2012-12-21 11:07:11
Documents
7
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v330120_10qa.htm 10-Q/A 27279
  Complete submission text file 0001144204-12-069143.txt   3120643

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT icpt-20120930.xml EX-101.INS 388622
3 XBRL TAXONOMY EXTENSION SCHEMA icpt-20120930.xsd EX-101.SCH 45993
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20120930_cal.xml EX-101.CAL 31171
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20120930_def.xml EX-101.DEF 165730
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20120930_lab.xml EX-101.LAB 277141
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20120930_pre.xml EX-101.PRE 206952
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35668 | Film No.: 121279852
SIC: 2834 Pharmaceutical Preparations